|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 16 2813-2819, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
DL Krebs and DJ Hilton
The Walter and Eliza Hall Institute of Medical Research and the Cooperative Research Center for Cellular Growth Factors, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia. krebs@wehi.edu.au
Cytokines regulate cellular behavior by interacting with receptors on the plasma membrane of target cells and activating intracellular signal transduction cascades such as the JAK-STAT pathway. Suppressors of cytokine signaling (SOCS) proteins negatively regulate cytokine signaling. The SOCS family consists of eight proteins: SOCS1-SOCS7 and CIS, each of which contains a central Src-homology 2 (SH2) domain and a C-terminal SOCS box. The expression of CIS, SOCS1, SOCS2 and SOCS3 is induced in response to stimulation by a wide variety of cytokines, and overexpression of these proteins in cell lines results in inhibition of cytokine signaling. Thus, SOCS proteins appear to form part of a classical negative feedback loop. The analysis of mice lacking SOCS1 has revealed that it is critical in the negative regulation of IFN(gamma) signaling and in the differentiation of T cells. Additionally, the analysis of mouse embryos lacking SOCS3 suggests that SOCS3 negatively regulates fetal liver erythropoiesis, probably through its ability to modulate erythropoietin (Epo) signaling. Thus, the use of gene targeting has confirmed that SOCS proteins regulate cytokine signaling in a physiological setting.
This article has been cited by other articles:
![]() |
J.-H. Kim, J. E. Kim, H.-Y. Liu, W. Cao, and J. Chen Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway J. Biol. Chem., January 11, 2008; 283(2): 708 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Feng, N. S. Allen, S. Simo, and J. A. Cooper Cullin 5 regulates Dab1 protein levels and neuron positioning during cortical development Genes & Dev., November 1, 2007; 21(21): 2717 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis Regulation of Suppressor of Cytokine Signaling 3 (SOC3) by Growth Hormone in Pro-B Cells Mol. Endocrinol., October 1, 2007; 21(10): 2503 - 2515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis Characterization of the SOCS3 Promoter Response to Prostaglandin E2 in T47D Cells Mol. Endocrinol., October 1, 2007; 21(10): 2516 - 2528. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells J. Biol. Chem., February 2, 2007; 282(5): 3014 - 3026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samardzija, A. Wenzel, S. Aufenberg, M. Thiersch, C. Reme, and C. Grimm Differential role of Jak-STAT signaling in retinal degenerations FASEB J, November 1, 2006; 20(13): 2411 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Z. Michaylira, J. G. Simmons, N. M. Ramocki, B. P. Scull, K. K. McNaughton, C. R. Fuller, and P. K. Lund Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G472 - G481. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Larrea, R Aldabe, E Molano, C M Fernandez-Rodriguez, A Ametzazurra, M P Civeira, and J Prieto Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies Gut, August 1, 2006; 55(8): 1188 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ahmed, G. Yumet, M. Shumate, C. H. Lang, P. Rotwein, and R. N. Cooney Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G35 - G44. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Assou, T. Anahory, V. Pantesco, T. Le Carrour, F. Pellestor, B. Klein, L. Reyftmann, H. Dechaud, J. De Vos, and S. Hamamah The human cumulus-oocyte complex gene-expression profile Hum. Reprod., July 1, 2006; 21(7): 1705 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Walsh, J R Jonsson, M M Richardson, G M Lipka, D M Purdie, A D Clouston, and E E Powell Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 Gut, April 1, 2006; 55(4): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gentili, M. J. Waters, and I. C. McMillen Differential regulation of suppressor of cytokine signaling-3 in the liver and adipose tissue of the sheep fetus in late gestation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1044 - R1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Qasimi, A. Ming-Lum, A. Ghanipour, C. J. Ong, M. E. Cox, J. Ihle, N. Cacalano, A. Yoshimura, and A. L-F. Mui Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor {alpha} and Nitric Oxide Production by Macrophages J. Biol. Chem., March 10, 2006; 281(10): 6316 - 6324. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shi, B. Cave, K. Inouye, C. Bjorbaek, and J. S. Flier Overexpression of Suppressor of Cytokine Signaling 3 in Adipose Tissue Causes Local but Not Systemic Insulin Resistance Diabetes, March 1, 2006; 55(3): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. MacRae, C. Farquharson, and S. F. Ahmed The pathophysiology of the growth plate in juvenile idiopathic arthritis Rheumatology, January 1, 2006; 45(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Laubner, T. J. Kieffer, N. T. Lam, X. Niu, F. Jakob, and J. Seufert Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic {beta}-Cells Diabetes, December 1, 2005; 54(12): 3410 - 3417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Shumate, G. Yumet, T. A. Ahmed, and R. N. Cooney Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G227 - G239. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sandra, I. Bataillon, P. Roux, J. Martal, G. Charpigny, P. Reinaud, P. Bolifraud, G. Germain, and K. H Al-Gubory Suppressor of cytokine signalling (SOCS) genes are expressed in the endometrium and regulated by conceptus signals during early pregnancy in the ewe J. Mol. Endocrinol., June 1, 2005; 34(3): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Haring, G. A. Corbin, and J. T. Harty Dynamic Regulation of IFN-{gamma} Signaling in Antigen-Specific CD8+ T Cells Responding to Infection J. Immunol., June 1, 2005; 174(11): 6791 - 6802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Biddinger, K. Almind, M. Miyazaki, E. Kokkotou, J. M. Ntambi, and C. R. Kahn Effects of Diet and Genetic Background on Sterol Regulatory Element-Binding Protein-1c, Stearoyl-CoA Desaturase 1, and the Development of the Metabolic Syndrome Diabetes, May 1, 2005; 54(5): 1314 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Astolfi, L. Landuzzi, G. Nicoletti, C. De Giovanni, S. Croci, A. Palladini, S. Ferrini, M. Iezzi, P. Musiani, F. Cavallo, et al. Gene Expression Analysis of Immune-Mediated Arrest of Tumorigenesis in a Transgenic Mouse Model of HER-2/neu-Positive Basal-Like Mammary Carcinoma Am. J. Pathol., April 1, 2005; 166(4): 1205 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Boverhof, E. Tam, A. S. Harney, R. B. Crawford, N. E. Kaminski, and T. R. Zacharewski 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Suppressor of Cytokine Signaling 2 in Murine B Cells Mol. Pharmacol., December 1, 2004; 66(6): 1662 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells Diabetes, December 1, 2004; 53(suppl_3): S97 - S103. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Park, K.-A. Ji, S.-B. Jeon, W.-H. Choi, I.-o. Han, H.-J. You, J.-H. Kim, I. Jou, and E.-H. Joe Rac1 Contributes to Maximal Activation of STAT1 and STAT3 in IFN-{gamma}-Stimulated Rat Astrocytes J. Immunol., November 1, 2004; 173(9): 5697 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Krebs, D. Metcalf, T. D. Merson, A. K. Voss, T. Thomas, J.-G. Zhang, S. Rakar, M. K. O'Bryan, T. A. Willson, E. M. Viney, et al. Development of hydrocephalus in mice lacking SOCS7 PNAS, October 26, 2004; 101(43): 15446 - 15451. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schick, E. J. Oakeley, N. E. Hynes, and A. Badache TEL/ETV6 Is a Signal Transducer and Activator of Transcription 3 (Stat3)-induced Repressor of Stat3 Activity J. Biol. Chem., September 10, 2004; 279(37): 38787 - 38796. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tong and H. F. Lodish Lnk Inhibits Tpo-mpl Signaling and Tpo-mediated Megakaryocytopoiesis J. Exp. Med., September 7, 2004; 200(5): 569 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, L. M. Gronning, P. O. Anderson, S. Li, K. Edvardsen, J. Johnston, D. Kioussis, P. R. Shepherd, and P. Wang Insulin Induces SOCS-6 Expression and Its Binding to the p85 Monomer of Phosphoinositide 3-Kinase, Resulting in Improvement in Glucose Metabolism J. Biol. Chem., August 13, 2004; 279(33): 34107 - 34114. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shi, I. Tzameli, C. Bjorbaek, and J. S. Flier Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling J. Biol. Chem., August 13, 2004; 279(33): 34733 - 34740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Komazaki, H. Nagai, M. Emi, Y. Terada, A. Yabe, E. Jin, O. Kawanami, N. Konishi, Y. Moriyama, T. Naka, et al. Hypermethylation-associated Inactivation of the SOCS-1 Gene, a JAK/STAT Inhibitor, in Human Pancreatic Cancers Jpn. J. Clin. Oncol., April 1, 2004; 34(4): 191 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Woelfle and P. Rotwein In vivo regulation of growth hormone-stimulated gene transcription by STAT5b Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E393 - E401. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wormald and D. J. Hilton Inhibitors of Cytokine Signal Transduction J. Biol. Chem., January 9, 2004; 279(2): 821 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsukawa, K. Takeda, S. Kudo, T. Maeda, M. Kagayama, and S. Akira Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils J. Immunol., December 1, 2003; 171(11): 6198 - 6205. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Calegari, R. M. N. Bezerra, M. A. Torsoni, A. S. Torsoni, K. G. Franchini, M. J. A. Saad, and L. A. Velloso Suppressor of Cytokine Signaling 3 Is Induced by Angiotensin II in Heart and Isolated Cardiomyocytes, and Participates in Desensitization Endocrinology, October 1, 2003; 144(10): 4586 - 4596. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pal and A. Sahu Leptin Signaling in the Hypothalamus during Chronic Central Leptin Infusion Endocrinology, September 1, 2003; 144(9): 3789 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roes, B. K. Choi, and B. B. Cazac Redirection of B cell responsiveness by transforming growth factor {beta} receptor PNAS, June 10, 2003; 100(12): 7241 - 7246. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gomez and N. C. Reich Stimulation of Primary Human Endothelial Cell Proliferation by IFN J. Immunol., June 1, 2003; 170(11): 5373 - 5381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Senn, P. J. Klover, I. A. Nowak, T. A. Zimmers, L. G. Koniaris, R. W. Furlanetto, and R. A. Mooney Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes J. Biol. Chem., April 11, 2003; 278(16): 13740 - 13746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Denson, M. A. Held, R. K. Menon, S. J. Frank, A. F. Parlow, and D. L. Arnold Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3 Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G646 - G654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Ormandy, M. Naylor, J. Harris, F. Robertson, N. D. Horseman, G. J. Lindeman, J. Visvader, and P. A. Kelly Investigation of the Transcriptional Changes Underlying Functional Defects in the Mammary Glands of Prolactin Receptor Knockout Mice Recent Prog. Horm. Res., January 1, 2003; 58(1): 297 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes Diabetes, December 1, 2002; 51(12): 3391 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilangumaran, D. Finan, J. La Rose, J. Raine, A. Silverstein, P. De Sepulveda, and R. Rottapel A Positive Regulatory Role for Suppressor of Cytokine Signaling 1 in IFN-{gamma}-Induced MHC Class II Expression in Fibroblasts J. Immunol., November 1, 2002; 169(9): 5010 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rui, M. Yuan, D. Frantz, S. Shoelson, and M. F. White SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2 J. Biol. Chem., October 25, 2002; 277(44): 42394 - 42398. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Greenhalgh, D. Metcalf, A. L. Thaus, J. E. Corbin, R. Uren, P. O. Morgan, L. J. Fabri, J.-G. Zhang, H. M. Martin, T. A. Willson, et al. Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling J. Biol. Chem., October 18, 2002; 277(43): 40181 - 40184. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishida, K. Hayashi, M. Hoshijima, T. Ogawa, S. Koga, Y. Miyatake, M. Kumegawa, T. Kimura, and T. Takeya Large Scale Gene Expression Analysis of Osteoclastogenesis in Vitro and Elucidation of NFAT2 as a Key Regulator J. Biol. Chem., October 18, 2002; 277(43): 41147 - 41156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Curlewis, S. P. Tam, P. Lau, D. H. L. Kusters, J. L. Barclay, S. T. Anderson, and M. J. Waters A Prostaglandin F2{alpha} Analog Induces Suppressors of Cytokine Signaling-3 Expression in the Corpus Luteum of the Pregnant Rat: A Potential New Mechanism in Luteolysis Endocrinology, October 1, 2002; 143(10): 3984 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Park, H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell, and M. P. Lisanti Caveolin-1-deficient Mice Show Accelerated Mammary Gland Development During Pregnancy, Premature Lactation, and Hyperactivation of the Jak-2/STAT5a Signaling Cascade Mol. Biol. Cell, October 1, 2002; 13(10): 3416 - 3430. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yumet, M. L. Shumate, P. Bryant, C.-M. Lin, C. H. Lang, and R. N. Cooney Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E472 - E481. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Krebs, R. T. Uren, D. Metcalf, S. Rakar, J.-G. Zhang, R. Starr, D. P. De Souza, K. Hanzinikolas, J. Eyles, L. M. Connolly, et al. SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation Mol. Cell. Biol., July 1, 2002; 22(13): 4567 - 4578. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Greenhalgh, P. Bertolino, S. L. Asa, D. Metcalf, J. E. Corbin, T. E. Adams, H. W. Davey, N. A. Nicola, D. J. Hilton, and W. S. Alexander Growth Enhancement in Suppressor of Cytokine Signaling 2 (SOCS-2)-Deficient Mice Is Dependent on Signal Transducer and Activator of Transcription 5b (STAT5b) Mol. Endocrinol., June 1, 2002; 16(6): 1394 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Leonard, K. Hannan, M. J. Burne, D. W. P. Lappin, P. Doran, P. Coleman, C. Stenson, C. T. Taylor, F. Daniels, C. Godson, et al. 15-Epi-16-(Para-Fluorophenoxy)-Lipoxin A4-Methyl Ester, a Synthetic Analogue of 15-epi-Lipoxin A4, Is Protective in Experimental Ischemic Acute Renal Failure J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1657 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. Mysorekar, M. A. Mulvey, S. J. Hultgren, and J. I. Gordon Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli J. Biol. Chem., February 22, 2002; 277(9): 7412 - 7419. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Emanuelli, P. Peraldi, C. Filloux, C. Chavey, K. Freidinger, D. J. Hilton, G. S. Hotamisligil, and E. Van Obberghen SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-alpha in the Adipose Tissue of Obese Mice J. Biol. Chem., December 14, 2001; 276(51): 47944 - 47949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Pritchard, L. Hsu, J. Delrow, and P. S. Nelson Project normal: Defining normal variance in mouse gene expression PNAS, November 6, 2001; 98(23): 13266 - 13271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bousquet, V. Chesnokova, A. Kariagina, A. Ferrand, and S. Melmed cAMP Neuropeptide Agonists Induce Pituitary Suppressor of Cytokine Signaling-3: Novel Negative Feedback Mechanism for Corticotroph Cytokine Action Mol. Endocrinol., November 1, 2001; 15(11): 1880 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ling and H. Billig PRL Receptor-Mediated Effects in Female Mouse Adipocytes: PRL Induces Suppressors of Cytokine Signaling Expression and Suppresses Insulin-Induced Leptin Production in Adipocytes in Vitro Endocrinology, November 1, 2001; 142(11): 4880 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, September 26, 2001; (2001) 211445998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Roberts, L. Robb, S. Rakar, L. Hartley, L. Cluse, N. A. Nicola, D. Metcalf, D. J. Hilton, and W. S. Alexander Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3 PNAS, July 31, 2001; 98(16): 9324 - 9329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Heldin Signal Transduction: Multiple Pathways, Multiple Options for Therapy Stem Cells, July 1, 2001; 19(4): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Lindeman, S. Wittlin, H. Lada, M. J. Naylor, M. Santamaria, J.-G. Zhang, R. Starr, D. J. Hilton, W. S. Alexander, C. J. Ormandy, et al. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice Genes & Dev., July 1, 2001; 15(13): 1631 - 1636. [Abstract] |